Cargando…

MAGE-C2/CT10 Protein Expression Is an Independent Predictor of Recurrence in Prostate Cancer

The cancer-testis (CT) family of antigens is expressed in a variety of malignant neoplasms. In most cases, no CT antigen is found in normal tissues, except in testis, making them ideal targets for cancer immunotherapy. A comprehensive analysis of CT antigen expression has not yet been reported in pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	von Boehmer, Lotta, Keller, Lukas, Mortezavi, Ashkan, Provenzano, Maurizio, Sais, Giovanni, Hermanns, Thomas, Sulser, Tullio, Jungbluth, Achim A., Old, Lloyd J., Kristiansen, Glen, van den Broek, Maries, Moch, Holger, Knuth, Alexander, Wild, Peter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130772/ https://www.ncbi.nlm.nih.gov/pubmed/21754986 http://dx.doi.org/10.1371/journal.pone.0021366

Ejemplares similares

Expression of MAGE-C1/CT7 and MAGE-C2/CT10 Predicts Lymph Node Metastasis in Melanoma Patients
por: Curioni-Fontecedro, Alessandra, et al.
Publicado: (2011)

Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores
por: Ikenberg, Kristian, et al.
Publicado: (2010)

Antibody response to BK polyomavirus as a prognostic biomarker and potential therapeutic target in prostate cancer
por: Keller, Xavier Etienne, et al.
Publicado: (2015)

Retroperitoneal teratoma with somatic malignant transformation: A papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum-based chemotherapy
por: Zeh, Nina, et al.
Publicado: (2013)

Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death
por: Mortezavi, Ashkan, et al.
Publicado: (2017)

Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma
por: Dannenmann, Stefanie Regine, et al.
Publicado: (2013)

Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer
por: Poyet, Cédric, et al.
Publicado: (2014)

γ-Radiation Promotes Immunological Recognition of Cancer Cells through Increased Expression of Cancer-Testis Antigens In Vitro and In Vivo
por: Sharma, Anu, et al.
Publicado: (2011)

Radiotherapy supports protective tumor-specific immunity
por: Gupta, Anurag, et al.
Publicado: (2012)

Periostin is up-regulated in high grade and high stage prostate cancer
por: Tischler, Verena, et al.
Publicado: (2010)

High VEGF-D and Low MMP-2 Serum Levels Predict Nodal-Positive Disease in Invasive Bladder Cancer
por: Benoit, Tobias, et al.
Publicado: (2015)

Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer
por: Poyet, Cédric, et al.
Publicado: (2015)

Implication of vascular endothelial growth factor A and C in revealing diagnostic lymphangiogenic markers in node-positive bladder cancer
por: Poyet, Cédric, et al.
Publicado: (2017)

Expression of cancer/testis antigens MAGE-A, MAGE-C1, GAGE and CTAG1B in benign and malignant thyroid diseases
por: Melo, Daniel Hardy, et al.
Publicado: (2017)

Comprehensive immunohistochemical analysis of PD-L1 shows scarce expression in castration-resistant prostate cancer
por: Fankhauser, Christian D., et al.
Publicado: (2017)

Therapy decisions after diagnosis of prostate cancer in men with negative prostate MRI
por: Schmid, Florian A., et al.
Publicado: (2022)

A curated collection of tissue microarray images and clinical outcome data of prostate cancer patients
por: Zhong, Qing, et al.
Publicado: (2017)

Frequent MAGE Mutations in Human Melanoma
por: Caballero, Otavia L., et al.
Publicado: (2010)

Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours
por: Jungbluth, A A, et al.
Publicado: (2000)

Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma
por: Curioni-Fontecedro, A., et al.
Publicado: (2015)

Expression of Indoleamine 2,3-Dioxygenase Induced by IFN-γ and TNF-α as Potential Biomarker of Prostate Cancer Progression
por: Banzola, Irina, et al.
Publicado: (2018)

Correction: Frequent MAGE Mutations in Human Melanoma
por: Caballero, Otavia L., et al.
Publicado: (2010)

CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors
por: Fankhauser, Christian Daniel, et al.
Publicado: (2019)

Erratum to “Intratumoral Heterogeneity of MAGE-C1/CT7 and MAGE-C2/CT10 Expression in Mucosal Melanoma”
por: Curioni-Fontecedro, A., et al.
Publicado: (2019)

An overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients
por: Inaoka, Riguel J, et al.
Publicado: (2011)

Oxygen supply maps for hypoxic microenvironment visualization in prostate cancer
por: Rupp, Niels J., et al.
Publicado: (2016)

Comprehensive validation of published immunohistochemical prognostic biomarkers of prostate cancer—what has gone wrong? A blueprint for the way forward in biomarker studies
por: Huber, F, et al.
Publicado: (2015)

Therapy-resistant nephrolithiasis following renal artery coil embolization
por: Poyet, Cédric, et al.
Publicado: (2013)

CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer
por: Wettstein, Marian S., et al.
Publicado: (2015)

ProCOC: The prostate cancer outcomes cohort study
por: Umbehr, Martin, et al.
Publicado: (2008)

The expression of the cancer testis antigen MAGE A4: A favorable prognostic biomarker in salivary gland carcinomas related to low tumor grading
por: Vital, Domenic, et al.
Publicado: (2018)

Pathogenicity of the MAGE family
por: Li, Sanyan, et al.
Publicado: (2021)

In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine
por: Junwei, Wang, et al.
Publicado: (2016)

Erratum to: In vivo enhancement of the MAGE-specific cellular immune response by a recombinant MAGE1-MAGE3-TBHSP70 tumor vaccine
por: Junwei, Wang, et al.
Publicado: (2017)

Effectiveness of Flexible Ureterorenoscopy Versus Extracorporeal Shock Wave Lithotripsy for Renal Calculi of 5–15 mm: Results of a Randomized Controlled Trial
por: Fankhauser, Christian Daniel, et al.
Publicado: (2021)

MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer
por: Suzuki, S, et al.
Publicado: (2008)

The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer
por: Weber, Achim, et al.
Publicado: (2008)

Miltiwire proportional chambers MAGE spectrometer
por: Gusev, K E, et al.
Publicado: (2003)

CRMAGE: CRISPR Optimized MAGE Recombineering
por: Ronda, Carlotta, et al.
Publicado: (2016)

MAGE-A Antigens and Cancer Immunotherapy
por: Zajac, Paul, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v94qmboomc1lorj9d6o081m7dt